Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Guidelines search

Búsqueda de Guías

  • Perinatal HIV Clinical Guidelines (93)
  • HIV Clinical Guidelines: Pediatric ARV (84)
  • HIV Clinical Guidelines: Adult and Adolescent ARV (67)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (44)
  • (-) HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (40)
  • Guidance for Caring for People With HIV Displaced by Disasters (4)
Resultados de la búsqueda 21 – 40 de 40
Malaria
Microsporidiosis
Mpox
Disseminated Mycobacterium avium Complex Disease
Mycobacterium tuberculosis Infection and Disease
Progressive Multifocal Leukoencephalopathy/JC Virus Infection
Pneumocystis Pneumonia
Syphilis
Talaromycosis (Formerly Penicilliosis)
Toxoplasmosis
Varicella-Zoster Virus Disease
Tables
Table 1. Chemoprophylaxis to Prevent First Episode of Opportunistic Disease
Table 2. Treatment of HIV-Associated Opportunistic Infections (Includes Recommendations for Acute Treatment and Secondary Prophylaxis/Chronic Suppressive/Maintenance Therapy)
Table 3. Indications for Discontinuing and Restarting Primary and Secondary Prophylaxis (or Chronic Maintenance Therapy) for Selected Opportunistic Infections in Adults and Adolescents with HIV
Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections
Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections
Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections that Require Dosage Adjustment in Adults With Renal Insufficiency
Appendix A: List of Abbreviations
Appendix B: Panel Roster and Financial Disclosures

Paginación

  • Primera página ‹‹
  • Página anterior ‹
  • Página 1
  • Página actual 2

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.